Home > Healthcare > Medical Devices > Therapeutic Devices > Bare Metal Stents Market
Bare Metal Stents Market size was anticipated to be worth over USD 434 million in 2022 and it is expected to reach around USD 567.1 million by 2032, witnessing an 2.8% growth rate over the forecast period. The market is influenced by several pointers, including factors or conditions stimulating industry growth, owing to increasing incidence of coronary artery disease, rising advancements in stent design and materials, growing aging population, and increasing awareness among others.
In addition, BMS are often more cost-effective than their drug-eluting counterparts because they don't require the extended use of expensive antiplatelet medications. This cost-effectiveness can be particularly appealing in regions with limited healthcare budgets.Moreover, in numerous countries, healthcare reimbursement policies play a significant role in determining the adoption of medical devices like bare metal stents. Favorable reimbursement policies can encourage healthcare providers to choose stents as a treatment option for coronary artery disease, thereby boosting market progress.
Bare metal stent (BMS) is a medical device used in the field of interventional cardiology and vascular surgery to treat narrowed or blocked blood vessels, typically arteries, in a procedure called angioplasty. It is a metallic scaffold, usually made of stainless steel or other biocompatible metals, designed to be implanted permanently within a narrowed blood vessel to help restore blood flow.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Bare Metal Stents Market Size in 2022: | USD 434.9 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 2.8% |
2032 Value Projection: | USD 567.1 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 150 |
Tables, Charts & Figures: | 270 |
Segments covered: | Product, Material Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|